National Clinical Trials Network: Lead Academic Participating Site at Dartmouth Cancer Center
Official title: NCI National Clinical Trials Network - Network Lead Academic Participating Site (UG1)
Funded at Dartmouth-Hitchcock Clinic · NIH-11291599 · Data updated 2026-11-12
A major cancer center in northern New England will continue coordinating and leading nationwide clinical trials to bring cutting-edge treatments to patients in Vermont, New Hampshire, and surrounding rural areas.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dartmouth-Hitchcock Clinic NIH-funded |
| Lab location | 1 site (Lebanon, United States) |
| Project start | March 15, 2019 |
| Project end | February 29, 2032 |
| Funding year | 2026 |
| Award (this year) | $500,430 |
| NIH project number | 2UG1CA233323-07 |
| Project ID | NIH-11291599 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with advanced or rare cancers located in northern New England who are willing to participate in multi-center clinical trials.
✕Less likely to help
Patients whose cancer type is not part of active trials or who are ineligible for trial enrollment may not benefit.
What this research studies
This grant supports Dartmouth Cancer Center in sustaining its role as a Lead Academic Participating Site within the National Clinical Trials Network, coordinating multiple national trials across a network of community sites. The center will leverage its experience and infrastructure to enroll patients in innovative trials and ensure high-quality study conduct. Patients with advanced cancers in rural regions may gain access to experimental therapies and state-of-the-art care through participating sites across the catchment area.
Why it matters
Potential benefit: Patients in rural and underserved areas may gain timely access to cutting-edge cancer treatments through national trials.
How similar studies have gone: Past collaborations with national networks have led to successful trial enrollment and access to innovative therapies.
Where this research is happening
-
Dartmouth-Hitchcock Clinic
Lebanon, United States Active
Researchers
- Principal investigator: Dragnev, Konstantin H. — Dartmouth-Hitchcock Clinic
- Study coordinator: Dragnev, Konstantin H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.